RxDoctor Payments Data

Elizabeth Judd

Psychiatric/Mental Health, Child & Family · Saint Louis, MONPI 1629021597

Payments from drug & device makers

$16,251in general payments, 2019–2025

Across 170 payments — averaging $95.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$14K
  • AbbVie$775
  • Otsuka America Pharmaceutical, Inc.$441
  • Takeda Pharmaceuticals U.S.A., Inc.$233
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$186
  • Lundbeck LLC$139
  • plus $570 from 8 others

What the payments were for

  • Speaking & faculty fees$11,25069%
  • Travel & lodging$1,5179%
  • Food & beverage$3,48321%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few psychiatric/mental health, child & family providers in Missourito place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lamotrigine ErLamotrigine13$2,443
Vilazodone Hcl12$729
Ziprasidone Hcl12$452
Ondansetron Hcl11$148
Lamotrigine15$136

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health, child & family in Saint Louis

Where these figures come from

Is this you, or does something look wrong? →